Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Stem Cells (Dayton, Ohio)
|
January 1, 1994
The mobilization of primitive hemopoietic progenitors into the peripheral blood
P J Simmons, D I Leavesley, J P Levesque, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults
A A Cardoso, M L Li, P Batard, et al.
Leukemia & Lymphoma
|
May 1, 1996
CD44 and hyaluronan binding by human myeloid cells
F Smadja-Joffe, S Legras, N Girard, et al.
The Review of Scientific Instruments
|
July 5, 2013
In situ "artificial plasma" calibration of tokamak magnetic sensors
D Shiraki, J P Levesque, J Bialek, et al.
Leukemia
|
September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
D Karpova, K Dauber, G Spohn, et al.
Tissue Antigens
|
February 26, 2005
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis
B Jorgensen-Tye, J-P Levesque, L Royle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor
R Doyonnas, J Yi-Hsin Chan, L H Butler, et al.
Blood
|
May 16, 2000
Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues
S M Watt, L H Butler, M Tavian, et al.
Leukemia
|
April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
C E Forristal, A L Brown, F M Helwani, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Stem Cells (Dayton, Ohio)
|
January 1, 1994
The mobilization of primitive hemopoietic progenitors into the peripheral blood
P J Simmons, D I Leavesley, J P Levesque, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults
A A Cardoso, M L Li, P Batard, et al.
Leukemia & Lymphoma
|
May 1, 1996
CD44 and hyaluronan binding by human myeloid cells
F Smadja-Joffe, S Legras, N Girard, et al.
The Review of Scientific Instruments
|
July 5, 2013
In situ "artificial plasma" calibration of tokamak magnetic sensors
D Shiraki, J P Levesque, J Bialek, et al.
Leukemia
|
September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
D Karpova, K Dauber, G Spohn, et al.
Tissue Antigens
|
February 26, 2005
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis
B Jorgensen-Tye, J-P Levesque, L Royle, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor
R Doyonnas, J Yi-Hsin Chan, L H Butler, et al.
Blood
|
May 16, 2000
Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues
S M Watt, L H Butler, M Tavian, et al.
Leukemia
|
April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
C E Forristal, A L Brown, F M Helwani, et al.
Page
of 4